NCT06029647View on ClinicalTrials.gov

Mangos to Reduce Cardiometabolic Risk Markers

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 18, 2023

Primary Completion Date

September 12, 2024

Study Completion Date

September 12, 2024

Conditions
Healthy
Interventions
OTHER

Mango

The participants will consume the treatment for 16 weeks, followed by a 4-week washout period.

OTHER

vanilla wafers

vanilla wafers

Trial Locations (1)

91768

California State Polytechnic University, Pomona, Pomona

All Listed Sponsors
lead

California State Polytechnic University, Pomona

OTHER

NCT06029647 - Mangos to Reduce Cardiometabolic Risk Markers | Biotech Hunter | Biotech Hunter